Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 4
Results: 12
Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 444, doi. 10.1002/cpdd.792
- By:
- Publication type:
- Article
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 466, doi. 10.1002/cpdd.786
- By:
- Publication type:
- Article
A Two‐Sequence, Four‐Period, Crossover, Replicate Study to Demonstrate Bioequivalence of Warfarin Sodium Tablet in Healthy Chinese Subjects Under Fasting and Fed Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 527, doi. 10.1002/cpdd.783
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 514, doi. 10.1002/cpdd.782
- By:
- Publication type:
- Article
Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open‐Label Crossover Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 486, doi. 10.1002/cpdd.777
- By:
- Publication type:
- Article
Absolute Bioavailability of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation–Positive Malignancies.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 496, doi. 10.1002/cpdd.773
- By:
- Publication type:
- Article
Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 428, doi. 10.1002/cpdd.769
- By:
- Publication type:
- Article
Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 456, doi. 10.1002/cpdd.757
- By:
- Publication type:
- Article
A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 476, doi. 10.1002/cpdd.747
- By:
- Publication type:
- Article
Comparing the Pharmacokinetics of 2 Novel Intravenous Tramadol Dosing Regimens to Oral Tramadol: A Randomized 3‐Arm Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 537, doi. 10.1002/cpdd.746
- By:
- Publication type:
- Article
Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 505, doi. 10.1002/cpdd.735
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 4, p. 423, doi. 10.1002/cpdd.678
- Publication type:
- Article